PERTUSSIS WHOOPING COUGH
Clinical trials for PERTUSSIS WHOOPING COUGH explained in plain language.
Never miss a new study
Get alerted when new PERTUSSIS WHOOPING COUGH trials appear
Sign up with your email to follow new studies for PERTUSSIS WHOOPING COUGH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Thousands monitored in whooping cough vaccine safety sweep
⭐️ VACCINE ⭐️ CompletedThis study checked the safety of the VacPertagen vaccine for whooping cough after it was already approved in Thailand. Over 5,400 people, including pregnant women, were watched for side effects. The goal was to make sure the vaccine is safe for the general public.
Matched conditions: PERTUSSIS WHOOPING COUGH
Sponsor: BioNet-Asia Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 15:58 UTC
-
Thousands monitored in Real-World vaccine safety study
⭐️ VACCINE ⭐️ CompletedThis study checked the safety of the TdaP vaccine Boostagen® after it was already approved in Thailand. Over 10,000 people who got the vaccine in regular doctor visits were watched for side effects. The goal was to see how safe the vaccine is in a large, real-world group, includi…
Matched conditions: PERTUSSIS WHOOPING COUGH
Sponsor: BioNet-Asia Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 05, 2026 11:54 UTC
-
New whooping cough vaccine shows promise in toddler trial
Disease control CompletedThis study tested a new booster vaccine (DTaPgen) in 290 healthy toddlers aged 15 to 36 months to see if it works as well as a current vaccine against whooping cough. The new vaccine uses a safer, genetically detoxified pertussis toxin. The goal was to compare immune response and…
Matched conditions: PERTUSSIS WHOOPING COUGH
Phase: PHASE2, PHASE3 • Sponsor: BioNet-Asia Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 06:49 UTC